ACADIA Pharmaceuticals Inc (ACAD)
17.55
+0.35
(+2.03%)
USD |
NASDAQ |
Nov 08, 15:40
ACADIA Pharmaceuticals Revenue (TTM): 929.24M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 929.24M |
| June 30, 2024 | 890.53M |
| March 31, 2024 | 813.81M |
| December 31, 2023 | 726.44M |
| September 30, 2023 | 631.89M |
| June 30, 2023 | 550.90M |
| March 31, 2023 | 520.23M |
| December 31, 2022 | 517.24M |
| September 30, 2022 | 511.50M |
| June 30, 2022 | 512.40M |
| March 31, 2022 | 493.06M |
| December 31, 2021 | 484.14M |
| September 30, 2021 | 474.39M |
| June 30, 2021 | 463.36M |
| March 31, 2021 | 458.24M |
| December 31, 2020 | 441.76M |
| September 30, 2020 | 419.07M |
| June 30, 2020 | 393.08M |
| March 31, 2020 | 366.18M |
| December 31, 2019 | 339.08M |
| September 30, 2019 | 300.32M |
| June 30, 2019 | 264.04M |
| March 31, 2019 | 237.90M |
| December 31, 2018 | 223.81M |
| September 30, 2018 | 207.80M |
| Date | Value |
|---|---|
| June 30, 2018 | 185.07M |
| March 31, 2018 | 158.48M |
| December 31, 2017 | 124.90M |
| September 30, 2017 | 93.30M |
| June 30, 2017 | 62.99M |
| March 31, 2017 | 32.61M |
| December 31, 2016 | 17.33M |
| September 30, 2016 | 5.386M |
| June 30, 2016 | 0.157M |
| March 31, 2016 | 0.061M |
| December 31, 2015 | 0.061M |
| September 30, 2015 | 0.092M |
| June 30, 2015 | 0.068M |
| March 31, 2015 | 0.095M |
| December 31, 2014 | 0.121M |
| September 30, 2014 | 0.11M |
| June 30, 2014 | 0.335M |
| March 31, 2014 | 0.758M |
| December 31, 2013 | 1.145M |
| September 30, 2013 | 1.488M |
| June 30, 2013 | 4.726M |
| March 31, 2013 | 4.874M |
| December 31, 2012 | 4.907M |
| September 30, 2012 | 5.115M |
| June 30, 2012 | 2.221M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
339.08M
Minimum
Dec 2019
929.24M
Maximum
Sep 2024
546.83M
Average
502.28M
Median
Revenue (TTM) Benchmarks
| Biogen Inc | 9.608B |
| Madrigal Pharmaceuticals Inc | -- |
| Supernus Pharmaceuticals Inc | 651.97M |
| Geovax Labs Inc | -- |
| Myomo Inc | 25.24M |